BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Mancuso A. Hepatocellular carcinoma in thalassemia: A critical review. World J Hepatol 2010; 2(5): 171-174 [PMID: 21160991 DOI: 10.4254/wjh.v2.i5.171]
URL: https://www.wjgnet.com/1948-5182/full/v2/i5/171.htm
Number Citing Articles
1
Hassan M. Moukhadder, Racha Halawi, Maria Domenica Cappellini, Ali T. Taher. Reply to Management of hepatocellular carcinoma in thalassemia and importance of the human factorCancer 2017; 123(6): 1073 doi: 10.1002/cncr.30550
2
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2017; : 2961 doi: 10.1007/978-3-319-26956-6_165
3
Sandeep Soni. Gene therapies for transfusion dependent β‐thalassemia: Current status and critical criteria for successAmerican Journal of Hematology 2020; 95(9): 1099 doi: 10.1002/ajh.25909
4
Hassan M. Moukhadder, Racha Halawi, Maria Domenica Cappellini, Ali T. Taher. Hepatocellular carcinoma as an emerging morbidity in the thalassemia syndromes: A comprehensive reviewCancer 2017; 123(5): 751 doi: 10.1002/cncr.30462
5
Said Y. Mohamed. Thalassemia Major: Transplantation or Transfusion and ChelationHematology/Oncology and Stem Cell Therapy 2017; 10(4): 290 doi: 10.1016/j.hemonc.2017.05.022
6
Irene Motta, Marta Mancarella, Alessia Marcon, Marco Vicenzi, Maria Domenica Cappellini. Management of age-associated medical complications in patients with β-thalassemiaExpert Review of Hematology 2020; 13(1): 85 doi: 10.1080/17474086.2020.1686354
7
Khaled M. Musallam, Irene Motta, Marta Salvatori, Mirella Fraquelli, Alessia Marcon, Ali T. Taher, Maria Domenica Cappellini. Longitudinal changes in serum ferritin levels correlate with measures of hepatic stiffness in transfusion-independent patients with β-thalassemia intermediaBlood Cells, Molecules, and Diseases 2012; 49(3-4): 136 doi: 10.1016/j.bcmd.2012.06.001
8
Huang-Kai Peng, I-Ling Lin, Chien-Chih Lee, Li-Ya Wang, Cherng-Chyi Tzeng, Jan-Gowth Chang, Shyh-Chyun Yang. Synthesis and antitumor activity evaluation of anilinoquinoline derivatives by the effect on the expression of polo-like kinaseMedicinal Chemistry Research 2014; 23(3): 1437 doi: 10.1007/s00044-013-0749-3
9
John C. Wood. Use of Magnetic Resonance Imaging to Monitor Iron OverloadHematology/Oncology Clinics of North America 2014; 28(4): 747 doi: 10.1016/j.hoc.2014.04.002
10
Andrea Mancuso. Management of hepatocellular carcinoma in thalassemia and importance of the human factorCancer 2017; 123(6): 1071 doi: 10.1002/cncr.30551
11
Joseph E. Maakaron, Maria Domenica Cappellini, Giovanna Graziadei, Jad Bou Ayache, Ali T. Taher. Hepatocellular carcinoma in hepatitis-negative patients with thalassemia intermedia: A closer look at the role of siderosisAnnals of Hepatology 2013; 12(1): 142 doi: 10.1016/S1665-2681(19)31397-3
12
Roberta D’Ambrosio, Erika Poggiali, Maria Domenica Cappellini. Treating hepatitis C in patients with hemoglobinopathiesExpert Opinion on Orphan Drugs 2015; 3(11): 1267 doi: 10.1517/21678707.2015.1086333
13
Current status of beta‐thalassemia and its treatment strategiesMolecular Genetics & Genomic Medicine 2021; 9(12) doi: 10.1002/mgg3.1788
14
Jung Wha Chung, Eun Shin, Haeryoung Kim, Ho-Seong Han, Jai Young Cho, Young Rok Choi, Sukho Hong, Eun Sun Jang, Jin-Wook Kim, Sook-Hyang Jeong. Hepatic iron overload in the portal tract predicts poor survival in hepatocellular carcinoma after curative resectionLiver International 2018; 38(5): 903 doi: 10.1111/liv.13619
15
Andrea Mancuso, Giovanni Perricone. Time to define a new strategy for management of hepatocellular carcinoma in thalassaemia?British Journal of Haematology 2015; 168(2): 304 doi: 10.1111/bjh.13098
16
Paul I. Tyan, Amr H. Radwan, Assaad Eid, Anthony G. Haddad, David Wehbe, Ali T. Taher. Novel Approach to Reactive Oxygen Species in Nontransfusion-Dependent ThalassemiaBioMed Research International 2014; 2014: 1 doi: 10.1155/2014/350432
17
Andrea Mancuso. Management of hepatocellular carcinoma: Enlightening the gray zonesWorld Journal of Hepatology 2013; 5(6): 302-310 doi: 10.4254/wjh.v5.i6.302
18
Maher Malaeb, Ali T. Taher, Ala I. Sharara. Liver Cancer in the Middle East2021; : 371 doi: 10.1007/978-3-030-78737-0_23
19
Antoine Finianos, Charbel Matar, Ali Taher. Hepatocellular Carcinoma in β-Thalassemia Patients: Review of the Literature with Molecular Insight into Liver CarcinogenesisInternational Journal of Molecular Sciences 2018; 19(12): 4070 doi: 10.3390/ijms19124070
20
Adriana Ceci, Laura Mangiarini, Fedele Bonifazi, Rossella Conte. Multidisciplinary Care in HaemoglobinopathiesThalassemia Reports 2014; 4(3): 4875 doi: 10.4081/thal.2014.4875
21
Mohammad Hassan Hodroj, Rayan Bou-Fakhredin, Wared Nour-Eldine, Hussein A. Noureldine, Mohammad Hassan A. Noureldine, Ali T. Taher. Thalassemia and malignancy: An emerging concern?Blood Reviews 2019; 37: 100585 doi: 10.1016/j.blre.2019.06.002
22
Silvia Fargion, Luca Valenti, Anna Ludovica Fracanzani. Role of iron in hepatocellular carcinomaClinical Liver Disease 2014; 3(5): 108 doi: 10.1002/cld.350
23
João Arezes, Niall Foy, Kirsty McHugh, Doris Quinkert, Susan Benard, Anagha Sawant, Joe N. Frost, Andrew E. Armitage, Sant-Rayn Pasricha, Pei Jin Lim, May S. Tam, Edward Lavallie, Debra D. Pittman, Orla Cunningham, Matthew Lambert, John E. Murphy, Simon J. Draper, Reema Jasuja, Hal Drakesmith. Antibodies against the erythroferrone N-terminal domain prevent hepcidin suppression and ameliorate murine thalassemiaBlood 2020; 135(8): 547 doi: 10.1182/blood.2019003140
24
Andrea Mancuso. Evidence-based medicine and Management of Hepatocellular Carcinoma in ThalassemiaBMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01542-2
25
Racha Halawi, Irene Motta, Ali Taher, Maria Domenica Cappellini. Deferasirox: an orphan drug for chronic iron overload in non-transfusion dependent thalassemia syndromesExpert Opinion on Orphan Drugs 2016; 4(6): 677 doi: 10.1080/21678707.2016.1182018
26
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2016; : 1 doi: 10.1007/978-3-319-26587-2_165-1
27
Khaled M. Musallam, Maria D. Cappellini, John C. Wood, Ali T. Taher. Iron overload in non-transfusion-dependent thalassemia: a clinical perspectiveBlood Reviews 2012; 26: S16 doi: 10.1016/S0268-960X(12)70006-1
28
Hassan M. Moukhadder, Joseph E. Roumi, Rayan Bou-Fakhredin, Ali T. Taher. Hepatocellular Carcinoma in a β-Thalassemia Intermedia Patient: Yet Another Case in the Expanding EpidemicHemoglobin 2018; 42(1): 58 doi: 10.1080/03630269.2018.1434197
29
Paschalis Paschos, Efthimia Vlachaki, Chrisoula Pasvanti, Emmanouil Sinakos, Anastasia Kalpaka, Philippos Klonizakis, Vasilios Perifanis. Safety and Efficacy of Combination Therapy with Pegylated Interferon Alpha-2a and Ribavirin in Treating Patients with Chronic Hepatitis C and Beta-Thalassaemia Major: A Greek Single-Center ExperienceActa Haematologica 2011; 126(4): 231 doi: 10.1159/000330516
30
Christine C. Hsu, Nizar H. Senussi, Kleber Y. Fertrin, Kris V. Kowdley. Iron overload disordersHepatology Communications 2022; 6(8): 1842 doi: 10.1002/hep4.2012
31
Pierre Brissot, Olivier Loreal. Management of Liver Complications in HaemoglobinopathiesThalassemia Reports 2014; 4(3): 4869 doi: 10.4081/thal.2014.4869